vs
アクサルタ（AXTA）とEncompass Health Corp（EHC）の財務データ比較。上の社名をクリックして会社を切り替えられます
Encompass Health Corpの直近四半期売上が大きい（$1.5B vs $1.3B、アクサルタの約1.2倍）。Encompass Health Corpの純利益率が高く（9.5% vs 4.8%、差は4.7%）。Encompass Health Corpの前年同期比売上増加率が高い（9.9% vs -3.7%）。アクサルタの直近四半期フリーキャッシュフローが多い（$286.0M vs $116.7M）。過去8四半期でEncompass Health Corpの売上複合成長率が高い（8.3% vs -1.2%）
アクサルタは米国発祥の塗料専門企業で、本社はペンシルベニア州フィラデルフィア、登記所在地はバミューダである。乗用車・商用車向け、工業用、補修用の各種塗料の開発・製造を手がけ、130か国以上で事業を展開し、約1万3千人の従業員を擁している。
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
AXTA vs EHC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $1.3B | $1.5B |
| 純利益 | $60.0M | $146.1M |
| 粗利率 | 33.4% | — |
| 営業利益率 | 12.8% | 16.7% |
| 純利益率 | 4.8% | 9.5% |
| 売上前年比 | -3.7% | 9.9% |
| 純利益前年比 | -56.2% | 20.8% |
| EPS（希薄化後） | $0.28 | $1.43 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.3B | $1.5B | ||
| Q2 25 | $1.3B | $1.5B | ||
| Q1 25 | $1.3B | $1.5B | ||
| Q4 24 | $1.3B | $1.4B | ||
| Q3 24 | $1.3B | $1.4B | ||
| Q2 24 | $1.4B | $1.3B | ||
| Q1 24 | $1.3B | $1.3B |
| Q4 25 | $60.0M | $146.1M | ||
| Q3 25 | $110.0M | $126.5M | ||
| Q2 25 | $109.0M | $142.1M | ||
| Q1 25 | $99.0M | $151.5M | ||
| Q4 24 | $137.0M | $120.9M | ||
| Q3 24 | $101.0M | $108.2M | ||
| Q2 24 | $112.0M | $114.1M | ||
| Q1 24 | $41.0M | $112.5M |
| Q4 25 | 33.4% | — | ||
| Q3 25 | 34.9% | — | ||
| Q2 25 | 35.0% | — | ||
| Q1 25 | 34.3% | — | ||
| Q4 24 | 34.1% | — | ||
| Q3 24 | 35.0% | — | ||
| Q2 24 | 34.0% | — | ||
| Q1 24 | 33.2% | — |
| Q4 25 | 12.8% | 16.7% | ||
| Q3 25 | 15.8% | 14.9% | ||
| Q2 25 | 14.8% | 16.2% | ||
| Q1 25 | 13.9% | 16.4% | ||
| Q4 24 | 14.3% | 14.3% | ||
| Q3 24 | 14.6% | 13.6% | ||
| Q2 24 | 15.2% | 14.3% | ||
| Q1 24 | 9.4% | 13.6% |
| Q4 25 | 4.8% | 9.5% | ||
| Q3 25 | 8.5% | 8.6% | ||
| Q2 25 | 8.4% | 9.7% | ||
| Q1 25 | 7.8% | 10.4% | ||
| Q4 24 | 10.5% | 8.6% | ||
| Q3 24 | 7.7% | 8.0% | ||
| Q2 24 | 8.3% | 8.8% | ||
| Q1 24 | 3.2% | 8.5% |
| Q4 25 | $0.28 | $1.43 | ||
| Q3 25 | $0.51 | $1.24 | ||
| Q2 25 | $0.50 | $1.39 | ||
| Q1 25 | $0.45 | $1.48 | ||
| Q4 24 | $0.63 | $1.18 | ||
| Q3 24 | $0.46 | $1.06 | ||
| Q2 24 | $0.51 | $1.12 | ||
| Q1 24 | $0.18 | $1.10 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $657.0M | $72.2M |
| 総負債低いほど良い | $3.2B | $2.4B |
| 株主資本純資産 | $2.3B | $2.4B |
| 総資産 | $7.6B | $7.1B |
| 負債/資本比率低いほどレバレッジが低い | 1.36× | 1.00× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $657.0M | $72.2M | ||
| Q3 25 | $606.0M | $48.7M | ||
| Q2 25 | $625.0M | $99.1M | ||
| Q1 25 | $575.0M | $95.8M | ||
| Q4 24 | $593.0M | $85.4M | ||
| Q3 24 | $567.0M | $147.8M | ||
| Q2 24 | $840.0M | $154.4M | ||
| Q1 24 | $624.0M | $134.4M |
| Q4 25 | $3.2B | $2.4B | ||
| Q3 25 | $3.4B | $2.4B | ||
| Q2 25 | $3.4B | $2.3B | ||
| Q1 25 | $3.4B | $2.3B | ||
| Q4 24 | $3.4B | $2.4B | ||
| Q3 24 | $3.5B | $2.3B | ||
| Q2 24 | $3.6B | $2.7B | ||
| Q1 24 | $3.4B | $2.7B |
| Q4 25 | $2.3B | $2.4B | ||
| Q3 25 | $2.3B | $2.4B | ||
| Q2 25 | $2.3B | $2.3B | ||
| Q1 25 | $2.1B | $2.2B | ||
| Q4 24 | $1.9B | $2.1B | ||
| Q3 24 | $1.9B | $2.0B | ||
| Q2 24 | $1.8B | $1.8B | ||
| Q1 24 | $1.7B | $1.7B |
| Q4 25 | $7.6B | $7.1B | ||
| Q3 25 | $7.8B | $6.9B | ||
| Q2 25 | $7.8B | $6.8B | ||
| Q1 25 | $7.4B | $6.6B | ||
| Q4 24 | $7.2B | $6.5B | ||
| Q3 24 | $7.5B | $6.5B | ||
| Q2 24 | $7.3B | $6.4B | ||
| Q1 24 | $7.1B | $6.2B |
| Q4 25 | 1.36× | 1.00× | ||
| Q3 25 | 1.48× | 1.01× | ||
| Q2 25 | 1.50× | 1.02× | ||
| Q1 25 | 1.64× | 1.08× | ||
| Q4 24 | 1.78× | 1.14× | ||
| Q3 24 | 1.84× | 1.20× | ||
| Q2 24 | 2.02× | 1.46× | ||
| Q1 24 | 1.97× | 1.54× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $344.0M | $346.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $286.0M | $116.7M |
| FCFマージンFCF / 売上 | 22.7% | 7.6% |
| 設備投資強度設備投資 / 売上 | 4.6% | 14.8% |
| キャッシュ転換率営業CF / 純利益 | 5.73× | 2.37× |
| 直近12ヶ月FCF直近4四半期 | $453.0M | $439.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $344.0M | $346.0M | ||
| Q3 25 | $137.0M | $270.8M | ||
| Q2 25 | $142.0M | $270.2M | ||
| Q1 25 | $26.0M | $288.6M | ||
| Q4 24 | $234.0M | $278.8M | ||
| Q3 24 | $194.0M | $267.8M | ||
| Q2 24 | $114.0M | $217.4M | ||
| Q1 24 | $34.0M | $238.8M |
| Q4 25 | $286.0M | $116.7M | ||
| Q3 25 | $87.0M | $83.7M | ||
| Q2 25 | $97.0M | $113.3M | ||
| Q1 25 | $-17.0M | $125.5M | ||
| Q4 24 | $172.0M | $80.1M | ||
| Q3 24 | $161.0M | $120.3M | ||
| Q2 24 | $91.0M | $60.5M | ||
| Q1 24 | $12.0M | $99.4M |
| Q4 25 | 22.7% | 7.6% | ||
| Q3 25 | 6.8% | 5.7% | ||
| Q2 25 | 7.4% | 7.8% | ||
| Q1 25 | -1.3% | 8.6% | ||
| Q4 24 | 13.1% | 5.7% | ||
| Q3 24 | 12.2% | 8.9% | ||
| Q2 24 | 6.7% | 4.6% | ||
| Q1 24 | 0.9% | 7.6% |
| Q4 25 | 4.6% | 14.8% | ||
| Q3 25 | 3.9% | 12.7% | ||
| Q2 25 | 3.4% | 10.8% | ||
| Q1 25 | 3.4% | 11.2% | ||
| Q4 24 | 4.7% | 14.1% | ||
| Q3 24 | 2.5% | 10.9% | ||
| Q2 24 | 1.7% | 12.1% | ||
| Q1 24 | 1.7% | 10.6% |
| Q4 25 | 5.73× | 2.37× | ||
| Q3 25 | 1.25× | 2.14× | ||
| Q2 25 | 1.30× | 1.90× | ||
| Q1 25 | 0.26× | 1.90× | ||
| Q4 24 | 1.71× | 2.31× | ||
| Q3 24 | 1.92× | 2.48× | ||
| Q2 24 | 1.02× | 1.91× | ||
| Q1 24 | 0.83× | 2.12× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AXTA
| Refinish | $509.0M | 40% |
| Light Vehicle | $372.0M | 29% |
| Industrial | $282.0M | 22% |
| Commercial Vehicle | $99.0M | 8% |
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
